Fortail LS exercises an initial, surface deep, strategic due diligence process on several topics: team members qualifications and collaboration; business model; R&D planning and operations; IP; clinical affairs; competition; Regulatory strategy; QA operations. This review results in a preliminary report entailing Fortail LS’ view of the company, a validating view allows us to present the recommended investment opportunity to our network of investors.

Fortail LS provides strategic consultancy services to life sciences companies, utilizing our own and our network’s knowledge and experience in navigating the harsh waters of the life sciences industry. Ever changing regulations, continued disruptions, influence shifts, and additional unique challenges are the hurdles Fortail LS guides and helps you overcome.

Fortail LS’ maintains a growing circle of investors, based around the globe. Said investors range from seed to A series scale, most are intelligent investors offering strategic values to any life sciences company. As Fortail LS' compensation is independent of scale of investment. Thus, Fortail LS completes the circle, objectively serving both companies and investors.